B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 4 610 KRW 1.32% Market Closed
Market Cap: 262.5B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note

BioPlus Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

BioPlus Co Ltd
Capital Expenditures Peer Comparison

Comparables:
137310
E
294090
T
340570
H
205470
I
119610

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
B
BioPlus Co Ltd
KOSDAQ:099430
Capital Expenditures
-â‚©21.6B
CAGR 3-Years
-170%
CAGR 5-Years
-97%
CAGR 10-Years
N/A
SD Biosensor Inc
KRX:137310
Capital Expenditures
-â‚©144.7B
CAGR 3-Years
-38%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
E
EOFlow Co Ltd
KOSDAQ:294090
Capital Expenditures
-â‚©10.6B
CAGR 3-Years
-105%
CAGR 5-Years
-97%
CAGR 10-Years
N/A
T
T&L Co Ltd
KOSDAQ:340570
Capital Expenditures
-â‚©14.9B
CAGR 3-Years
-63%
CAGR 5-Years
-40%
CAGR 10-Years
N/A
H
Humasis Co Ltd
KOSDAQ:205470
Capital Expenditures
-â‚©22.4B
CAGR 3-Years
-18%
CAGR 5-Years
-76%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Capital Expenditures
-â‚©7B
CAGR 3-Years
31%
CAGR 5-Years
15%
CAGR 10-Years
-14%

See Also

What is BioPlus Co Ltd's Capital Expenditures?
Capital Expenditures
-21.6B KRW

Based on the financial report for Dec 31, 2023, BioPlus Co Ltd's Capital Expenditures amounts to -21.6B KRW.

What is BioPlus Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-97%

Over the last year, the Capital Expenditures growth was -222%. The average annual Capital Expenditures growth rates for BioPlus Co Ltd have been -170% over the past three years , -97% over the past five years .

Back to Top